Patenting Dolly | GenomeWeb

Patenting Dolly

No. You may not patent Dolly the cloned sheep. Dolly and other animal clones like her are too geneticially identical to her naturally occurring donors to be patented as human creations, the US Court of Appeals for the Federal Circuit in Washington said yesterday.

In a decision that could impact the genetic engineering and biomedical fields, the court upheld the ruling of the Patent Trial and Appeal Board, which said that the Roslin Institute researchers seeking to patent the Dolly clone, which was the world's first cloned mammal when she was unveiled in 1996.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.